Basic Information
Basic information for LINC02223-219-54aa
Peptide Name LINC02223-219-54aa
Genome Position chr5:17929430-17929591[+]
Species Human
Peptide Sequence MARRNPVQCVPQKSCLLGLNAANVTLILVFQVLPSQSYPLYIKLVLLYYVNLYS
Peptide Length 54
Unique No (LINC02223-203-54aa,LINC02223-205-54aa,LINC02223-206-54aa,LINC02223-207-54aa,LINC02223-208-54aa,LINC02223-212-54aa,LINC02223-213-54aa,LINC02223-214-54aa,LINC02223-215-54aa,LINC02223-216-54aa)
Grand Average of Hydropathicity 0.6167
Relative Molecular Mass 7084.17
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000249937;LINC02223
Transcript ID/Name ENST00000670782;LINC02223-219
Transcript Length 1596
Coding Ability 0.4392
DNA Sequence Corresponding to Peptide ATGGCAAGAAGAAATCCAGTTCAGTGTGTTCCTCAGAAATCTTGCCTCTTGGGACTAAATGCTGCAAATGTAACTCTTATCCTTGTTTTTCAAGTTTTACCATCTCAAAGCTATCCACTTTATATTAAATTAGTTCTGTTATATTATGTCAATTTGTATTCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :